With every passing day, new discoveries are made that lend support to the increasing and important role biomarker analysis and tumor profiling play in personalized cancer care. Caris Life Sciences® is actively participating in research to advance the understanding of molecular science, further enabling the delivery of precision medicine.

Spectrum of BAP1 mutations identified in diverse cancer lineages

A novel liquid biopsy method method for detection of breast cancer

The B-cell Lymphoma Specific Aptamer C10.36 Binds a Ribonucleoprotein Complex on the Cell Surface of Cancer Cells

Small non-coding RNA profiling from prostate cancer plasma by deep sequencing

Adaptive dynamic artificial polyligand targeting (ADAPT): A Method to identify exosomal proteins from a prostate cancer cell line

A comparative analysis of PD-L1 distribution in primary NSCLC and metastatic tumors to the lung

Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach

Molecular Variances Between Rectal and Left-Sided Colon Cancers (Presentation)

Molecular Variances Between Rectal and Left Sided Colon Cancers

Molecular characterization of squamous cell carcinoma of the anal canal (SCCA)